Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for severe traumatic brain injury
IRCT20130310012776N4Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of propranolol in traumatic brain injury (TBI) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Glasgow Outcome Score Extended. Started Dec 2017; status: completed.
02
Drugs
propranolol
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20130310012776N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130310012776N4.